COLL
Collegium Pharmaceutical Inc

1,594
Mkt Cap
$1.48B
Volume
272,264.00
52W High
$50.79
52W Low
$23.23
PE Ratio
28.38
COLL Fundamentals
Price
$45.60
Prev Close
$46.90
Open
$46.95
50D MA
$46.64
Beta
0.63
Avg. Volume
500,045.59
EPS (Annual)
$1.86
P/B
5.24
Rev/Employee
$1.77M
Loading...
Loading...
News
all
press releases
Eastern Bank Buys 45,508 Shares of Collegium Pharmaceutical, Inc. $COLL
Eastern Bank lifted its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 487.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·7d ago
News Placeholder
Corcept (CORT) Surges 9.8%: Is This an Indication of Further Gains?
Corcept (CORT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·14d ago
News Placeholder
Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio
MD is positioned for growth on stronger collections, payer mix and acquisitions, as shares jump 55.2% in six months, beating the industry's 6.7% gain.
Zacks·17d ago
News Placeholder
Why You Should Add Encompass Health to Your Portfolio Now
EHC's expanding rehabilitation hospital network, strong cash flow and growing patient volumes reinforce its market position.
Zacks·19d ago
News Placeholder
Here's Why You Should Retain Community Health Stock for Now
CYH shows improving occupancy, targeted acquisitions and divestitures and a rising cash flow outlook, making the hospital operator worth holding for now.
Zacks·19d ago
News Placeholder
Collegium Pharmaceutical (NASDAQ:COLL) Stock Price Down 5% - Here's What Happened
Collegium Pharmaceutical (NASDAQ:COLL) Shares Down 5% - Here's What Happened...
MarketBeat·20d ago
News Placeholder
Exchange Traded Concepts LLC Reduces Holdings in Collegium Pharmaceutical, Inc. $COLL
Exchange Traded Concepts LLC cut its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 67.7% in the third quarter, according to the company in its most recent disclosure with the...
MarketBeat·20d ago
News Placeholder
Pacer Advisors Inc. Sells 87,066 Shares of Collegium Pharmaceutical, Inc. $COLL
Pacer Advisors Inc. trimmed its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 25.8% during the 3rd quarter, according to the company in its most recent Form 13F filing...
MarketBeat·21d ago
News Placeholder
Here's Why Investors Should Hold Ensign Group Stock for Now
ENSG's 23-year dividend hike streak, strong acquisitions and revenue growth bolster its long-term investment appeal.
Zacks·24d ago
<
1
2
...
>

Latest COLL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.